- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–7 of 7
Background: Juvenile Idiopathic Arthritis
Background: Pediatric Lupus Erythematosus
Long-Term Clinical Outcomes: Overview
Presentation: Comparing Medications for Adults With Type 2 Diabetes
Keywords: long-term clinical outcomes | mortality | morbidity | cardiovascular disease | nephropathy
Shared Decisionmaking: What To Discuss With Your Patients
Clinical Questions Addressed by the CER (2 of 2)
Keywords: juvenile idiopathic arthritis | JIA | JRA | juvenile rheumatic arthritis | JCA | juvenile chronic arthritis | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | nonbiologic | non-biologic | assessment instrument | reliability | validity | responsiveness
Summary: Nonbiologic and Biologic DMARDs Compared With Conventional Anti-inflammatoryTreatments (1 of 2)
Keywords: juvenile idiopathic arthritis | JIA | JRA | juvenile rheumatoid arthritis | JCA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | TNF-alpha blockers | biologic DMARD | nonbiologic DMARD | non-biologic DMARD | methotrexate | disease activity | health status | erythrocyte sedimentation rate | ESR | radiographic
Background: Complications Associated With Chronic Hepatitis C Virus Infection
Keywords: background | hepatitis C | HCV | complications | cirrhosis | fibrosis | hepatocellular cancer
Your slide tray is being processed.